Brief: Editas Medicine Announces Q3 Results And Business Updates
04/11/2024 14:56
Nov 4 (Reuters) - Editas Medicine Inc EDIT.O :
* EDITAS MEDICINE ANNOUNCES THIRD QUARTER 2024 RESULTS AND
BUSINESS UPDATES
* EDITAS MEDICINE: EXPECTS EXISTING CASH, CASH EQUIVALENTS,
MARKETABLE SECURITIES TO FUND OPERATING EXPENSES & CAPEX INTO Q2
2026
* EDITAS MEDICINE INC: QTRLY LOSS PER SHARE $0.75
Source text: ID:nGNX7lFDTf
Further company coverage: EDIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Editas Medicine
See all newsEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview
Editas Medicine Q2 net loss narrows and beats estimates
Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Editas Medicine down after $125 mln stock-and-warrants offering